Taiwan - Delayed Quote TWD

Excelsior Medical Co., Ltd. (4104.TW)

86.40
0.00
(0.00%)
At close: May 21 at 1:30:09 PM GMT+8
Loading Chart for 4104.TW
  • Previous Close 86.40
  • Open 86.90
  • Bid --
  • Ask --
  • Day's Range 86.40 - 87.00
  • 52 Week Range 79.50 - 90.90
  • Volume 79,010
  • Avg. Volume 210,966
  • Market Cap (intraday) 14.118B
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) 18.15
  • EPS (TTM) 4.76
  • Earnings Date May 9, 2025
  • Forward Dividend & Yield 3.80 (4.40%)
  • Ex-Dividend Date Apr 24, 2025
  • 1y Target Est 92.00

Excelsior Medical Co., Ltd. sells medical supplies and equipment, medicines, and home medical devices in Taiwan, Hong Kong, the Philippines, and Malaysia. The company offers equipment for hemodialysis/plasma exchange; blood bag; artificial stoma; scar care products; and health appliances. It engages in the investment, real estate, and leasing businesses, as well as selling of precision instrument. Excelsior Medical Co., Ltd. was incorporated in 1988 and is based in New Taipei City, Taiwan.

www.excelsiormedical.com.tw

--

Full Time Employees

December 31

Fiscal Year Ends

Recent News: 4104.TW

View More

Performance Overview: 4104.TW

Trailing total returns as of 5/21/2025, which may include dividends or other distributions. Benchmark is TSEC CAPITALIZATION WEIGHTED ST (^TWII) .

YTD Return

4104.TW
4.99%
TSEC CAPITALIZATION WEIGHTED ST (^TWII)
5.34%

1-Year Return

4104.TW
4.41%
TSEC CAPITALIZATION WEIGHTED ST (^TWII)
2.67%

3-Year Return

4104.TW
78.31%
TSEC CAPITALIZATION WEIGHTED ST (^TWII)
35.05%

5-Year Return

4104.TW
140.62%
TSEC CAPITALIZATION WEIGHTED ST (^TWII)
98.07%

Compare To: 4104.TW

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 4104.TW

View More

Valuation Measures

Annual
As of 5/21/2025
  • Market Cap

    14.12B

  • Enterprise Value

    11.99B

  • Trailing P/E

    18.15

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    1.64

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    --

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    9.04%

  • Return on Assets (ttm)

    2.59%

  • Return on Equity (ttm)

    9.24%

  • Revenue (ttm)

    8.65B

  • Net Income Avi to Common (ttm)

    781.32M

  • Diluted EPS (ttm)

    4.76

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    3.4B

  • Total Debt/Equity (mrq)

    12.47%

  • Levered Free Cash Flow (ttm)

    258.43M

Research Analysis: 4104.TW

View More

Company Insights: 4104.TW

Research Reports: 4104.TW

View More

People Also Watch